8 insiders reported 45 Form 4 transactions for Structure Therapeutics Inc. (GPCR) over the past 18 months (most recent 2026-08-19). Recent activity: Lin Xichen (CHIEF SCIENTIFIC OFFICER) Buy 11,817 shares, Lin Xichen (CHIEF SCIENTIFIC OFFICER) Sell 11,817 shares, Berrios John Joseph (Chief Commercial Officer) Buy 140,766 shares, Lin Xichen (CHIEF SCIENTIFIC OFFICER) Buy 11,817 shares, Lin Xichen (CHIEF SCIENTIFIC OFFICER) Sell 11,817 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Buy | 11,817 | $4,018 |
| 2026-08-19 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | 11,817 | $0 |
| 2026-08-07 | Berrios John Joseph | Chief Commercial Officer | Buy | 140,766 | $0 |
| 2026-08-05 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Buy | 11,817 | $4,018 |
| 2026-08-05 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | 11,817 | $0 |
| 2026-07-15 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Buy | 23,634 | $8,036 |
| 2026-07-15 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | 23,634 | $0 |
| 2026-06-29 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Buy | 23,634 | $8,036 |
| 2026-06-29 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | 23,634 | $0 |
| 2026-04-23 | Lang Matthew | COO & GC | Buy | 184,614 | $0 |
| 2026-03-23 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Buy | 260,217 | $0 |
| 2026-03-23 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Buy | 75,897 | $0 |
| 2026-03-23 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Buy | 43,368 | $0 |
| 2026-03-23 | Hall Ashley | Chief Development Officer | Buy | 47,706 | $0 |
| 2026-03-23 | Yoon Jun | CHIEF FINANCIAL OFFICER | Buy | 104,085 | $0 |
| 2026-03-23 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Buy | 32,526 | $0 |
| 2026-03-05 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | 18,735 | $393,248 |
| 2026-03-05 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Sell | 53,454 | $1.1M |
| 2026-03-05 | Hall Ashley | Chief Development Officer | Sell | 4,836 | $101,508 |
| 2026-03-05 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Sell | 11,826 | $248,228 |
| 2026-03-05 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Sell | 11,313 | $237,460 |
| 2026-03-05 | Yoon Jun | CHIEF FINANCIAL OFFICER | Sell | 22,305 | $468,182 |
| 2025-09-22 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Sell | 8,106 | $62,740 |
| 2025-09-22 | Hall Ashley | Chief Development Officer | Sell | 6,021 | $46,603 |
| 2025-08-20 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Sell | 4,470 | $30,575 |
Source: SEC Form 4 filings · as of 2026-08-19